Orbimed Advisors reported a 4.8% stake in Spruce Biosciences SPRB · 132,200 sh · passive holder

Trade details

Type: 5% stake report
Report: 13G passive
Stake: 4.8%
Last report: First report
Shares held: 132,200 sh
Class: Common Stock, par value $0.0001 per share
Stock: Spruce Biosciences SPRB
Holder: Orbimed Advisors
Event date: 26/06/30
Filed: 26/08/14

4.8% stake · below 5%

Spruce Biosciences trades, last 26 weeks

What else happened in Spruce Biosciences around then

Filed or reported within 30 days of the trade day · 05/31~07/30

Orbimed Advisors's other 5% stake reports

Orbimed Advisors
5% stakeElectra Therapeutics
5% stake
Electra Therapeutics
ETRA
11% stake
6,885,170 sh
11% stake
Filed 09/25
Orbimed Advisors
5% stakeBraveheart Bio
5% stake
Braveheart Bio
BRVE
13.5% stake
12,175,159 sh
13.5% stake
Filed 09/10
Orbimed Advisors
5% stakeBraveheart Bio
5% stake
Braveheart Bio
BRVE
17.2% stake
12,175,159 sh
17.2% stake
Filed 08/18
Orbimed Advisors
5% stakeBlossomHill Therapeutics
5% stake
BlossomHill Therapeutics
BLSM
8.9% stake
2,714,279 sh
8.9% stake
Filed 08/18
Orbimed Advisors
5% stakeWhitehawk Therapeutics
5% stake
Whitehawk Therapeutics
WHWK
7.3% stake
3,934,296 sh
7.3% stake
Filed 08/14